NL-OMON37724已完成不适用
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study and an Open-Label Relative Bioavailability and Food Effect Study of VX-787 in Healthy Subjects - VX-787 SAD/MAD study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male and female subjects
- •18-55 yrs, inclusive
- •BMI: 18.0-31.0 kg/m2, inclusive
- •non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
Unknown
A Phase 1 study, oral VVZ2471 in healthy male volunteersKCT0008891Vivozon87
招募中
1 期
Investigation of AV411 in Healthy SubjectsHealthy subjectsOther -ACTRN12606000410550Avigen, Inc.16
尚未招募
1 期
A Phase 1, Randomized Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intermittent Consecutive Day Dosing Regimen of PRTX007 in Healthy Adultsassa VirusLassa VirusInfection - Other infectious diseasesACTRN12624000981527nited States Defense Threat Reduction Agency (DTRA)15
已完成
1 期
A Phase I, Randomised, Double-Blinded, Placebo Controlled, Safety and Pharmacokinetic Study of (Z)-Endoxifen in Healthy Female VolunteersEstrogen Receptor Positive (ER+) breast cancerCancer - BreastACTRN12619000961145Atossa Genetics AUS Pty Ltd25
已完成
1 期
A Phase I, Randomised, Double-Blinded, Placebo Controlled, Safety and Pharmacokinetic Study of (Z)-Endoxifen Tablets in Healthy Female VolunteersEstrogen Receptor Positive (ER+) Breast CancerCancer - BreastACTRN12619001623189Atossa Genetics Aus Pty Ltd12